⏳ Fetching live dividend data...
Home › Calculator › SYRS Dividend Calculator 2026
Syros Pharmaceuticals, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SYRS → $2.3255384804733726e+49M in 10 years · $1,937,948,156,349,808,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SYRS position with:
Real after-tax yield depends on where you live and how you hold SYRS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 850000.00% | 849997.20% | $85,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 800000.00% | 799997.20% | $80,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 912500.00% | 912497.20% | $91,250,000 / yr |
| 🇨🇦 TFSA | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 750000.00% | 749997.20% | $75,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 850000.00% | 849997.20% | $85,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 700000.00% | 699997.20% | $70,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 736250.00% | 736247.20% | $73,625,000 / yr |
| 🇫🇷 FR Taxable | 30% | 700000.00% | 699997.20% | $70,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SYRS pays quarterly — 4 times per year. Next ex-div: TBD.
How SYRS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SYRS sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2024-12-02 | 37,070 | $0.27 | $10.0K | ||
| Sale | 2024-11-25 | 134,713 | $0.27 | $35.7K | ||
| Sale | 2024-11-18 | 36,133 | $0.22 | $7.9K | ||
| Sale | 2024-11-18 | 12,099 | $0.20 | $2.4K | ||
| Sale | 2024-11-19 | 46,657 | $0.22 | $10.3K | ||
| Sale | 2024-11-18 | 134,797 | $0.20 | $26.9K | ||
| Sale | 2024-11-18 | 137,803 | $0.21 | $29.0K | ||
| M-Exempt | 2024-10-31 | 40,125 | — | — | ||
| M-Exempt | 2024-10-31 | 40,125 | — | — | ||
| M-Exempt | 2024-10-31 | 18,875 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SYRS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →